Merck last week agreed to pay nearly $5 billion to settle most of the claims generated by its nowwithdrawn painkiller Vioxx, said Matthew Herper and Robert Langreth in Forbes.com. Plaintiffs ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

The ADVANTAGE (Assessment of Differences between Vioxx And Naproxen To Ascertain Gastrointestinal Tolerability and Effectiveness) trial was devised by Merck´s marketing division in January 1999 ...

The most popular of these were Vioxx (Merck) and Celebrex (Pfizer). We studied how prescriptions for these two drugs for patients with osteoarthritis responded to changes in television advertising ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...